LANGUAGE AND DURATION
- Language: English
- Duration - 60 minutes
PRESENTERS
- Experts: Dr Julie Eisengart (Moderator) and Prof. Roberto Giugliani
SESSION AGENDA AND LEARNING OBJECTIVES
Session Agenda
- Introductions
- Case Study - Roberto Giugliani
- Expert Discussion
- Case Study - Julie Eisengart
- Expert Discussion
- Audience Q&A
- Close
Session Learning Objectives
- Exploring the diagnostic journey of the patient through the lens of a real-life case study examples
- Considering how the path to diagnosis could be improved for individuals and their families.
- Understanding the importance of an early diagnosis, the barriers to diagnosis and how they can be overcome.
COURSE DESCRIPTION
Misdiagnosis often leads to delayed recognition and treatment of Mucopolysaccharidosis (MPS), significantly affecting long-term patient outcomes. Commonly, MPS symptoms are mistaken for those of other ailments, leading to misdirected symptom management or referrals to inappropriate pediatric specialties. This can further delay accurate diagnosis and effective treatment. The Spot the Early Signs program is designed to combat conditions that are frequently underdiagnosed or diagnosed late. It focuses on diseases for which treatments exist and emphasizes the importance of early detection and intervention. These efforts are crucial for improving disease progression, enhancing patient quality of life, and increasing survival rates.
AUDIENCE
This educational activity is designed for an international audience of General Pediatricians, General Practitioners, Pediatric Endocrinologists, Pediatric Rheumatologists, and other physicians and healthcare professionals interested in Metabolic Diseases.